XTL Share Price
NASDAQ: XTLB | Others$0.00
+0.00 (0.00%) XTL Stock Performance
XTL Share Price Chart
$0.00$0.00
L
H
Corporate Actions
About XTL
XTL Biopharmaceuticals Ltd is an intellectual property-based company focused on the development, management, and commercialization of intellectual property. The Company is engaged in biotechnology through its subsidiary Psyga Bio and in the biopharmaceutical industry with hCDR1, a novel compound working via a novel mechanism of action for the treatment of Systemic Lupus Erythematosus (SLE) and a potential treatment for Sjogren's syndrome (SS). It focuses on the acquisition and development of proprietary products and late-stage pharmaceutical product candidates for the treatment of unmet clinical needs.
XTL Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $1.74 | $1.49 | -36.73% |
Oct 2026 | $2.17 | $2.35 | -9.42% |
Sep 2026 | $2.35 | $2.60 | -21.57% |
Aug 2026 | $2.70 | $3.31 | +13.14% |
Jul 2026 | $2.49 | $2.93 | +14.45% |
Jun 2026 | $2.30 | $2.56 | +6.22% |
May 2026 | $3.76 | $2.41 | -36.91% |
Apr 2026 | $2.44 | $3.82 | +40.96% |
Mar 2026 | $0.73 | $2.71 | +253.79% |
Feb 2026 | $0.83 | $0.77 | -11.95% |
Jan 2026 | $0.57 | $0.87 | +52.63% |
Dec 2025 | $0.85 | $0.57 | -30.23% |